1) Welcome to our #accredited#tweetorial on optimal mgt of #hyperkalemia in the patient with #CKD. Earn 0.5h #CME/CE credit by following this thread. I am Sourabh Sharma MD DNB FASN 🇮🇳 @iamnephrologist & u have found the ONLY source for CE credit delivered entirely on Twitter!
4) Re potassium #homeostasis: 98% of the body's K lies in intracellular space➡️ helping determine resting membrane potential & intracellular electronegativity.
10% of K secretion is via the colon (↑significantly in advancing CKD) 🔓kidney360.asnjournals.org/content/1/1/65#NephroNotes
6) Arrhythmia in Hyperkalemia
Moderate HyperK: Fast Na channel activation; ↑excitability/conduction velocity: Peaked T
Severe HyperK: Fast Na channel inactivation/Inwardly rectifying K channel activation: Wide QRS/Conduction block
🔓academic.oup.com/ndt/article/34…
11) A low-K diet is generally recommended in advanced #CKD, but @goKDIGO suggests interventional trials to determine optimal recommendations, as there is no direct evidence to link dietary K & serum K, and the benefits of K can’t be ignored
🔓kidney360.asnjournals.org/content/1/1/65 #NephroNotes
15) So when hyperK happens, how is it treated? Acutely:
👉IV calcium ↓cardiac membrane excitation (1-3 min)
👉Insulin/glucose & β agonist redistribute K to ICS (30-60 min) but not ↓total body K
👉β Agonists: short duration of effect (2-4hrs)
👉Sodium bicarbonate ↑K elimination
21) So now let's look at oral potassium binders, which are more useful in chronic mgt & can help facilitate #RAASi optimization. Which of the following binders has the most rapid onset of action after oral administration?
24) We were about to start talking about the oral K binders. (BTW earn MORE CE/#CME on this topic at cardiometabolic-ce.com/category/hyper…) Yes, prune juice is a K binder, but it's not quick, and it may make a bigger mess than Na polystyrene sulfonate. So the correct answer was D.
27) Start w/the old. Sodium/Calcium Polysterene Sulfonate clinical studies:
👉Limited evidence for effectiveness/safety
👉With sorbitol, can cause colonic necrosis
👉Nonselective for K, with affinity for Ca/Mg ions
👉Caution: Na & volume overload
🔓frontiersin.org/articles/10.33…
28) And then the new. First, #patiromer sorbitex calcium clinical studies:
👉Efficacy established in randomized, placebo-controlled, phase 2 and 3 trials (CKD/ HF/RAASi)
👉Onset of action~ 7 hours
👉No serious AEs
🔓frontiersin.org/articles/10.33… #NephPearls#FOAMed#MedEd
29) Sodium Zirconium Cyclosilicate (#SZC) clinical studies:
👉Efficacy & safety established in Ph 2 & 3 trials (#CKD/#HF/#DM/#RAASi)
👉assoc'd w/ ↑Bicarbonate
👉High selectivity for K & ammonium ions
👉fast onset, starts in small bowel
👉No serious AEs
🔓frontiersin.org/articles/10.33…
31) Treatment of #Hyperkalemia in #hemodialysis patients:
👉Hyperkalaemia contributes to mortality in HD (3-5% deaths)
👉K ⤴️is most common immediately post 3-day weekend break
👉Adjust dialysate K as per 🔓ukkidney.org/sites/renal.or…
32) In summary, the treatment of hyperkalemia is likely to evolve in the coming years with the availability of novel drugs & the development of new strategies to improve safety. Clinical decisions on when to treat & how aggressively to treat require a pt-centered approach ...
33) ... guided by the clinical setting and rate of change in serum K+ level. Patients with moderate levels of hyperkalemia pose the greatest dilemma, especially when acuity is low, but warrant intervention to avoid deterioration.
34) Severe hyperkalemia risks arrhythmias & cardiac arrest, therefore prompt recognition and intervention is required. How big a problem is it? In-hospital mortality is significantly higher in patients w/ hyperkalaemia (X%) hypokalaemia (Y%) vs normokalaemia (Z%). What are X,Y,Z?
35) Per NICE guidelines, the correct answer is B, more exactly hyperkalemia (18.1%) compared to those with hypokalemia (5.0%) or normokalemia (3.9%). Pts with severe hyperK (> 6.5 mmol/l) are most at risk & in one report (🔓pubmed.ncbi.nlm.nih.gov/23171442/), hospital mortality was 30.7%.
1) Welcome to a 🆕 #accredited #tweetorial on #Albuminuria: The Canary in the Coal Mine of #Kidney and #Cardiorenal #Disease. Our returning expert author is the wonderful teacher Edgar V. Lerma 🇵🇭 @edgarvlermamd
#Cardiorenal #Nephpearls #nephtwitter #FOAMed #CardioTwitter
2) The program is intended for #HCPs & is supported by an independent educational grant from Bayer. Statement of accreditation and faculty disclosures at . Follow this 🧵for 0.75hr 🆓 CE/#CMEcredit--all delivered right here on X!cardiometabolic-ce.com/disclosures/
3) A canary in a coal mine is an advanced warning of danger. The term originates from when miners carried caged canaries while at work; if there was any methane or carbon monoxide in the mine, the canary would die before the levels of the gas reached those hazardous to humans.
1) Welcome to a 🆕#accredited #tweetorial on the challenges clinicians face when managing #venous #thromboembolism in patients with #cancer: cancer-associated thrombosis or #CAT. Our expert faculty is #shematologist Jean Connors MD @connors_md at @BrighamWomens & @DanaFarber.
2a) The program is intended for #healthcare professionals & supported by an independent educational grant from Anthos Therapeutics. Statement of accreditation & faculty disclosures at .cardiometabolic-ce.com/disclosures/
2b) Earn 0.5 hr 🆓CE/#CME by following this 🧵 & follow us for more expert-authored #MedEd. #FOAMed #ONCSM @MedTweetorials #CardioTwitter #cvCoag
🚨See prior programs in this area, still available for MedEd credit, at .cardiometabolic-ce.com/category/antit…
1) Welcome to the next installment of our #MedEd series on the potential for selective inhibitors of coagulation Factor XI or XIa (#FXI/#XIa) for therapeutic anticoagulation. Catch up with us by viewing & earn 🆓CE/#CMEcredit if you haven't already!cardiometabolic-ce.com/antithrombotic…
2) That prior program shared and explained the results of the #LBCT data from #AZALEA_TIMI_71 at #AHA23. Lots has happened in the #FXI world since then, so it's time revisit and recap.
3) It's always an honor when expert #cardiologist and incredible #researcher #educator C. Michael Gibson @CMichaelGibson pens an #accredited #tweetorial for us, but in particular we welcome his view on the most recent data and evolving thinking about #FXI inhibition.
1) Welcome to a 🆕#LIVE #accredited #tweetorial posted from #Toronto and #WSC2023, where we have just seen top-line results of #ANNEXa_I, the FIRST randomized comparison between #andexanet_alfa & usual care in pts with anti-#FXa #DOAC-associated #ICH.
2) Our expert author is #ANNEXa_I investigator Ashkan Shoamanesh MD @Ash_Shoamanesh, #Stroke #Neurologist @HamHealthSci, Assoc Prof @McMasterU, & Director of Hemorrhagic Stroke Research Program & Scientist @PHRIresearch #FOAMed #FOAMcc #neurotwitter #cardiotwitter #MedEd
3) This program is supported by an independent educational grant from AstraZeneca. Statement of accreditation & faculty disclosures at . FOLLOW @cardiomet_ce for more expert-led 🆓CE/#CME delivered wholly on Twitter!cardiometabolic-ce.com/disclosures/
1a) Welcome to a 🆕#accredited tweetorial on Analyzing Safety Data for #siRNA for Lowering #LDL-C and #Lp(a). Our expert faculty is James A. Underberg, MD, MS, FACPM, FACP, MNLA @lipiddoc
#Cardiotwitter #FOAMed
1b) @lipiddoc is a #lipidologist🩺🧬@nyulangone @NYUCVDPrevent. He is President of the Foundation of @nationallipid, Past-President of both @nationallipid AND @LipidBoard, and is Director of @BHLipidClinic. @cardiomet_CE is proud to welcome @lipiddoc as new faculty!
2) This presentation was originally delivered by @lipiddoc at an accredited satellite symposium at @nationallipid's June 2023 congress. He shared the podium there with lipidology & #preventive #cardiology experts @alanbrownmd, @jpenamd, & @NP_ltl_a.
@MedTweetorials
1) Welcome to a 🆕#accredited tweetorial on Recent Advances in the Risk Assessment in Patients with Hyperlipidemia: Enhancing Precision and Reliability. Our expert faculty is Dr Nataliya Pyslar @NP_ltl_a, #Cardiologist& Lipid Specialist @CookCtyHealth.
#Cardiotwitter #FOAMed
2) This presentation was originally delivered by @NP_ltl_a at an accredited satellite symposium at @nationallipid's June 2023 congress. She shared the podium there with lipidology & #preventive #cardiology experts @alanbrownmd, @jpenamd, & @lipiddoc.
@MedTweetorials
3a) The symposium and this tweetorial were supported by an unrestricted educational grant from Novartis. Statement of accreditation & faculty disclosures at .cardiometabolic-ce.com/disclosures/